Skip to main content

Table 3 Univariate and multivariate analysis of prognostic factors in ovarian cancer

From: HHLA2 predicts better survival and exhibits inhibited proliferation in epithelial ovarian cancer

Variable Univariate Analysis Multivariate Analysis
HR P Value 95% CI HR P Value 95% CI
Expression of HHLA2 0.577 0.465 (0.132,2.523) 0.156 0.049 (0.025,0.992)
 Positive vs Negative
Age (years) 0.711 0.522 (0.250,2.019)    
 < 50 vs ≥ 50
Differentiation 0.53 0.399 (0.121,2.320)    
 Poor and moderate vs well
Pathologic type 0.439 0.275 (0.100,1.922)    
 Serous adenocarcinoma vs other
FIGO Stage 2.568 0.211 (0.586,11.248)    
 I and II vs III and IV
Ascites 0.275 0.211 (0.036,2.076)    
 Positive vs Negative
Vessel 1.618 0.641 (0.213,12.262)    
 Positive vs Negative
Lymph Node 1.763 0.376 (0.502,6.190)    
 Positive vs Negative
Relapse 1.142 0.789 (0.433,3.011)    
 Relapse vs No Relapse
Serum CA125 Before Surgery 22.49 0.469 (0.005,101,864.851)    
 < 35 vs ≥ 35
Platinum Sensitivity 4.32 0.003 (1.652,11.294) 14.14 0.002 (2.632,75.916)
 Sensitive vs Resistant
CA125 1.978 0.511 (0.259,15.137)    
 Positive vs Negative
ER 0.434 0.087 (0.167,1.128)    
 Positive vs Negative
PR 0.328 0.028 (0.121,0.889)    
 Positive vs Negative
  1. Bold values indicate P < 0.05
  2. ER Estrogen Receptor, PR Progesterone Receptor